Artificial Intelligence | April 8–10, 2019 | Boston, MA USA

Agenda

Monday, April 8, 2019

7:00 am - 8:00 am
7:00 am - 5:00 pm
8:00 am - 9:40 am
Bayer Ballroom

First Look

Nine rapid fire presentations on the applications of AI in Clinical Care

Moderator: Giles Boland, MD
  • Chair, Department of Radiology, BWH; Philip H. Cook Professor of Radiology, HMS
Moderator: Trung Do
  • VP, Business Development, Innovation, PHS
9:40 am - 9:55 am
9:55 am - 11:35 am
Bayer Ballroom

First Look

Nine rapid fire presentations on the applications of AI in Clinical Care

11:45 am - 1:00 pm

Discovery Café Sessions

Lunch with Top Leading Experts: Intensive sessions addressing cutting-edge artificial intelligence topics.

Applying AI to Save Lives During the Opioid Crisis

The U.S. is in the throes of a devastating epidemic of opioid addiction and overdose — some 130 people die in this country every day from opioids, says the National Institute on Drug Abuse. With a total economic cost of more than $78 billion a year, academic and industry organizations are harnessing AI to develop new tools that can help alleviate this national crisis. This session will discuss some of the AI-based strategies that academic and industry teams are leveraging to help clinical and public health officials better predict, identify, and treat opioid addiction, as well as some of the concerns around data privacy.

Moderator: Thomas Sequist, MD, Chief Quality & Safety Officer, PHS

Bob Burgin, CEO, Amplifire Healthcare Alliance

Carm Huntress, CEO, RxRevu Inc

Sarah Wakeman, MD, Medical Director, Substance Use Disorder Initiative, MGH; Assistant Professor, Medicine, HMS

Scott Weiner, MD, Director, Brigham Comprehensive Opioid Response and Education (B-CORE) Program, BWH; Assistant Professor, HMS

 

Community Hospitals: Key Component in Healthcare Transformation

Community hospitals are the largest sources of patient care in the U.S. As such, they represent a critical frontier in the transformation of health care. How are these organizations using AI and digital technologies to drive transformation? What are the key distinctions from academic medical centers? This session will address these and other critical topics that impact community hospitals and their essential, though often overlooked, role in health care.

Moderator: Michael Jaff, DO, President, NWH, PHS, Professor of Medicine, HMS

Fabien Beckers, PhD, CEO, Arterys

Joanna Geisinger, CEO, TORq Interface

John Miller, MD, Director, Retinal Imaging, MEE; Assistant Professor, Ophthalmology, HMS

Lee Schwamm, MD, Director, Center for TeleHealth and Exec Vice Chair, Neurology, MGH; Professor, Neurology, HMS

Tal Wenderow, CEO, Beyond Verbal

 

Digital Management of Diabetes

Across the full spectrum of patient care, the management of diabetes has been flooded with new technology and treatment options for both type 1 and type 2 diabetes – there is a range of new devices and software, including automatic insulin infusion systems, glucose sensors, AI-based algorithms and decision support tools, with artificial pancreas on the horizon. This session will focus on these areas as well as clinical use cases that highlight the value of AI.

Moderator: Deborah Wexler, MD, Clinical Director, Diabetes Center, MGH; Associate Professor, HMS

Marie McDonnell, MD, Section Chief and Director, Diabetes Program, BWH; Lecturer, HMS

Joshua Riff, MD, CEO, Onduo

 

Emergency Medicine

 

Mental Health and the Promise of AI

Moderator: Sabine Wilhelm, PhD, Chief of Psychology; Director, OCD and Related Disorders Program, MGH; Professor, Psychology, HMS

Thomas McCoy, MD, Director of Research, Center for Quantitative Health, MGH; Assistant Professor, Psychiatry & Medicine, HMS

Christopher Molaro, CEO, Neuroflow

David Silbersweig, MD, Chairman, Department of Psychiatry, BWH; Stanley Cobb Professor of Psychiatry, HMS

 

From Startup to Impact (Pharma and Diagnostics)

With all the hype surrounding AI, this session will focus on what really matters. Impact! Who is really moving the needle in life sciences today? This session will introduce you to five leading companies who will share their client stories over lunch.

Moderator: James Brink, MD, Radiologist-in-Chief, MGH; Juan M. Taveras Professor of Radiology, HMS

Alex Zharavoronkov, PhD, CEO, Insilico Medicine, Inc

1:00 pm - 1:15 pm
1:15 pm - 1:45 pm
Bayer Ballroom
1:45 pm - 2:35 pm
Bayer Ballroom

AMC AI Strategy: AI from the Top

  • Board Member, PHS; President Emerita and Professor of Neuroscience, MIT
  • Chief Data Science Officer, PHS; Vice Chairman, Radiology, MGH; Associate Professor, Radiology, HMS
  • Chief Academic Officer, PHS; Laurie Carrol Guthart Professor of Medicine, Academic Dean for Partners, HMS; 2019 Forum Co-Chair
  • Chief Clinical Officer, PHS; Professor of Medicine, HMS; 2019 Forum Co-Chair
2:35 pm - 3:25 pm
Bayer Ballroom

RWE and Trial Optimization in the AI Era

Moderator: Thomas Lynch, MD
  • EVP and CSO, R&D, Bristol-Myers Squibb
  • CMO, CSO, SVP Oncology, Flatiron Health
  • EVP MA&PV and Bayer CMO, Bayer AG
  • Chief Architect, Microsoft Healthcare
  • CEO, My Own Med Inc.
  • Executive Director, Clinical Trials Office, PHS; Associate Professor of Medicine, HMS
3:25 pm - 4:15 pm
Bayer Ballroom

AI Driven Value-Based Care

  • CEO, MGPO; Professor of Medicine, HMS
  • CEO, American Heart Association
  • EVP, President, Network Solutions Change Healthcare
  • Vice Chairman, Investment Banking and Managing Director Lazard Freres
  • CEO, NHS England
4:15 pm - 5:05 pm
Bayer Ballroom

Cardiovascular Care: Reinvented Through AI

Cardiovascular diseases remain the leading cause of death worldwide and a major source of health care spending, making this area ripe for AI-enabled innovations. Teams in academia and industry are pursuing a range of AI-based tools in cardiovascular medicine: from AI-powered drug discovery and diagnostics to automated cardiac image analyses and AI-guided care delivery pathways. Panelists will discuss these and other areas where AI is having a sizeable impact; the discussion will also include the perspectives of a patient who benefited from AI-enabled cardiovascular care.

  • Vice Chair for Scientific Innovation, Department of Medicine, BWH; Associate Professor of Medicine, HMS
  • President, Bayer Pharma Americas Region, Bayer
  • Director, Cardiac Imaging MR PET CT Program, MGH; Professor, Medicine, HMS
5:15 pm - 6:15 pm

Tuesday, April 9, 2019

7:00 am - 8:00 am
7:00 am - 5:00 pm
7:50 am - 8:00 am
Bayer Ballroom

Opening Remarks

  • Chief Innovation Officer, PHS; President, Partners HealthCare International
8:00 am - 8:50 am
Bayer Ballroom

Implementing AI in Cancer Care

  • Associate Surgeon, BWH; Richard E. Wilson Professor of Surgery in the Field of Surgical Oncology, HMS
  • Chief, Breast Imaging Division, MGH; Professor of Radiology, HMS
  • President and Co-Founder, LunaDNA
  • Delta Electronics Professor, Electrical Engineering and Computer Science Department, MIT
  • Director, Cancer Genome Analysis, Broad Institute; Professor of Pathology, HMS
  • CEO, insitro
8:50 am - 9:40 am
Bayer Ballroom

Imagining Medicine in the Year 2054

In 1984 Isaac Asimov was asked to predict what life in 2019 would be like. Using the same aperture, we as what will health care look like 35 years from now? What capabilities will clinicians have that they now struggle with? And what will be the biggest challenges? Current trends suggest that we will see some significant gains in the areas of cancer immunotherapy, gene therapy for devastating rare diseases, and treatments for common neuropsychiatric conditions, including schizophrenia and depression. Panelists will draw on their visionary perspective and will reflect on what to expect and why.

  • Director, Clinical Research, MGH; Professor of Medicine, HMS
  • Vice Chair for Scientific Innovation, Department of Medicine, BWH; Associate Professor of Medicine, HMS
  • Director, Cellular Immunotherapy Program, MGH; Assistant Professor, Medicine, HMS
  • Vice-Chair, Neurology, Director, Genetics and Aging Research Unit, MGH; Joseph P. and Rose F. Kennedy Professor of Neurology, HMS
  • CEO, Biogen
9:40 am - 10:10 am
10:10 am - 10:40 am
Bayer Ballroom
10:40 am - 11:30 am
Bayer Ballroom

CEO Roundtable

  • Chief Academic Officer, PHS; Laurie Carrol Guthart Professor of Medicine, Academic Dean for Partners, HMS; 2019 Forum Co-Chair
  • EVP and Chief Commercial Officer, Bristol-Myers Squibb
  • CEO, Philips
  • EVP, Head, Pharmaceuticals Research & Development, Bayer AG
  • CEO, Siemens Healthineers
  • CEO, GE Healthcare
11:45 am - 1:00 pm

Discovery Cafe Sessions

Lunch with Top Leading Experts: Intensive sessions addressing cutting-edge artificial intelligence topics.

Back Office of the Provider Future

Moderator: Peter Markell, EVP, Administration and Finance, CFO and Treasurer, PHS

Kent Ivanoff, CEO, VisitPay

Connie Moser, Chief Operating Officer, Verge Health

Brian Robertson, CEO, VisiQuate

 

Chief Digital Strategy Officer Roundtable

With the advent of healthcare AI-enabled technologies, this session brings together several chief digital health officers from a range of organizations. The discussion will address key tradeoffs in sequencing technology across academic medical centers; what technologies are being prioritized; and how consumer expectations are impacting the future delivery model of healthcare.

Moderator: Alistair Erskine, MD, Chief Digital Health Officer, PHS

Michael Anderes, Chief Innovation and Digital Health Officer, Froedtert Health; President, Inception Health

Adam Landman, MD, VP and CIO, Brigham Health; Associate Professor of Emergency Medicine, HMS

Aimee Quirk, CEO, innovationOchsner

Richard Zane, MD, Chief Innovation Officer, UCHealth; Professor and Chair,Department of Emergency Medicine, University of Colorado School of Medicine

 

Innovation Fellows: A New Model of Collaboration

The Innovation Fellows Program provides short-term, experiential career development opportunities for future leaders in health care focused on accelerating collaborative innovation between science and industry. It facilitates personnel exchanges between Harvard Medical School staff from Partners’ hospitals and participating biopharmaceutical, device, venture capital, digital health, payor and consulting firms. A successful example of open innovation, Fellows and Hosts learn from each other as they collaborate on projects ranging from clinical development to digital health & artificial intelligence to new care delivery models and industry disruption. Come listen to the experience and insights of our panelists, including Fellows, Industry Partners and hospital leadership, and learn how this new model of collaboration can deliver value and lead to broader relationships between industry and academia.

Moderator: Seema Basu, PhD, Market Sector Leader, Innovation, PHS

Peter Ho, MD, PhD, CMO, Boston Pharmaceuticals

Harry Orf, PhD, SVP, Research, MGH; Principal Associate, HMS

 

Last Mile: Fully Implementing AI in Healthcare

This session will focus on how radiology and pathology specialties are currently applying AI in the clinic. Where will it be built out first? What are the barriers and how will these challenges be overcome?

Moderator: Keith Dreyer, DO, PhD, Chief Data Science Officer, PHS; Vice Chairman, Radiology, MGH; Associate Professor, Radiology, HMS

Katherine Andriole, PhD, Director of Research Strategy and Operations, MGH & BWH CCDS; Associate Professor, Radiology, HMS

Samuel Aronson, Executive Director, IT, Personalized Medicine, PHS

Seth Hain, VP of R&D, Epic

Jonathan Teich, MD, PhD, Chief Medical Information Officer, InterSystems; Emergency Medicine, BWH

 

Reimagining Disease Management

Moderator: Sree Chaguturu, MD, Chief Population Health Officer, PHS; Assistant Professor, Medicine, HMS

Murray Brozinsky, Chief Strategy Officer, Conversa

Jean Drouin, MD, CEO, Clarify Health Solutions

Sandhya Rao, MD, Senior Medical Director, Population Health, PHS; Assistant Professor, Medicine, HMS

 

Standards and Regulation: The Emerging AI Framework

Moderator: Brent Henry, Member, Mintz Levin

Bethany Hills, Member/ Chair, FDA Practice, Mintz Levin

From Startup to Impact (Provider Solutions)

With all the hype surrounding AI, this session will focus on what really matters. Impact! Who is really moving the needle for healthcare providers today? This session will introduce you to five leading companies who will share their client stories over lunch.

Moderator: Meredith Fisher, PhD, Partner, Partners Innovation Fund, PHS

 

1:00 pm - 1:10 pm
1:10 pm - 2:00 pm
Bayer Ballroom

China: AI Enabled Healthcare Leadership

  • President, Novartis Institutes for Biomedical Research
  • CEO, Infervision
  • Managing Partner, Qiming Venture Partners
2:00 pm - 2:30 pm
Bayer Ballroom

1:1 Fireside Chat: Mark Benjamin, CEO, Nuance

Moderator: Peter Slavin, MD
  • President, MGH; Professor, Health Care Policy, HMS
  • CEO, Nuance Communications
2:30 pm - 3:00 pm
3:00 pm - 3:50 pm
Bayer Ballroom

Getting to the AI Investment Decision

  • VP, Venture & Managing Partner, Partners Innovation Fund, PHS
  • Managing Director, Bain Capital Life Sciences
  • Managing Partner, Polaris Partners
  • SVP, Strategy, Commercialization & Innovation, Amgen
  • Managing Director, Healthcare Group, Goldman Sachs
  • Partner, Google Ventures
3:50 pm - 4:20 pm
Bayer Ballroom
4:20 pm - 5:10 pm
Bayer Ballroom

Consumer Healthcare and New Models of Care Delivery

Moderator: Diana Nole
  • CEO, Wolters Kluwer Health
  • President, Global Strategy Group, Samsung; Founder, CareVisor
  • VP and Global CTO, Sales, Dell EMC
  • President, Health Platforms, Verily Life Sciences
  • VP and Chief Health Officer, IBM Corporation
  • SVP, Head of Innovation and Health Equity Microsoft Healthcare
5:15 pm - 6:15 pm

Wednesday, April 10, 2019

7:00 am - 12:00 pm
7:30 am - 9:30 am
Bayer Ballroom

Innovation Discovery Grant Awardee Presentations

Twelve clinical AI teams culled through the Innovation Discovery Grant program present their work illustrating how AI can be used to improve patient health and healthcare delivery. This session is designed for investors, entrepreneurs, investigators, and others who are interested in commercializing AI opportunities that are currently in development with support from the Innovation Office.

Moderator: David Louis, MD
  • Pathologist-in-Chief, MGH; Benjamin Castleman Professor of Pathology, HMS
9:30 am - 10:00 am
10:00 am - 10:30 am
Bayer Ballroom

1:1 Fireside Chat: Stefan Oelrich, Member of the Board of Management; President, Pharmaceutical, Bayer AG

Moderator: Betsy Nabel, MD
  • President, Brigham Health; Professor of Medicine, HMS
  • Member of the Board of Management, Bayer AG; President, Pharmaceutical, Bayer AG
10:30 am - 11:00 am
Bayer Ballroom

1:1 Fireside Chat: Deepak Chopra, MD, Founder, The Chopra Foundation

  • Vice-Chair, Neurology, Director, Genetics and Aging Research Unit, MGH; Joseph P. and Rose F. Kennedy Professor of Neurology, HMS
  • Founder, The Chopra Foundation
11:00 am - 11:50 am
Bayer Ballroom

Using AI to Predict and Monitor Human Performance and Neurological Disease

  • Chief of Neurology, Co-Director, Neurological Clinical Research Institute, MGH; Julieanne Dorn Professor of Neurology, HMS
  • Chief Scientist, Dolby Laboratories
  • Global Therapeutic Head, Neuroscience Janssen Research & Development
  • EVP and CMO, Biogen
  • CEO, Kitman Labs
11:50 am - 12:50 pm
Bayer Ballroom

Disruptive Dozen: 12 Technologies that will reinvent AI in the Next 12 Months

The culture of innovation throughout Partners HealthCare naturally fosters robust discussions about new “disruptive” technologies and which ones will have the biggest impact on health care. The Disruptive Dozen was created to identify and rank the technologies that Partners faculty feel will break through over the next decade to significantly improve health care. This year, the Disruptive Dozen focuses on relevant advances and opportunities in artificial intelligence (AI).

  • Chair, Department of Pathology, BWH; Ramzi S. Cotran Professor of Pathology, HMS
  • Associate Chief, Infection Control Unit, MGH; Assistant Professor, Medicine, HMS
1:00 pm - 1:10 pm
Bayer Ballroom